Who We Are

To Improve the Quality of Life for Everyone
  • 2020
    • Development of product lines (TBA)
    • SKIN ACTUALLY water essence cosmetic
      - Patent registration for SPM™ technology (USA)
  • 2019
    • Research and Development to prepare for consumer cosmetic product lines
    • Establishment of BIOCOZ GLOBAL Research and Development Center (Korea)
  • 2018
    • SPM™ clinical trial testing producing positive results
      - Supervision by Dr. Ju Hee Lee at Severance Hospital
    • R&D of DERM ACTUALLY
      - Dermatology Clinical testing for product preparation
    • BIOCOZ GLOBAL, INC. establishment of US branch corporation
  • 2017
    • Commencement of SPM™ clinical trials
      - Supervision by Dr. Ju Hee Lee at Severance Hospital
    • Certificate supporting the safety and efficacy of SPM™
      - Dr. Martin C. Mihm Jr., MD (Harvard Medical School)
    • Patent registration for SPM™ (Republic of Korea)
  • 2016
    • Commencement of in-vivo studies
      - Lead: Dr. Martin C. Mihm Jr., MD (Harvard Medical School)
    • Appointment set for Head of BIOCOZ GLOBAL Medical Advisory Board
      - Dr. Martin C. Mihm Jr., MD
  • 2015
    • Validation of in-vitro study results
      - Lead by Dr. Anthony J. Sinskey, Ph.D (Massachusetts Institute of Technology
    • Appointment set as Head of BIOCOZ GLOBAL Scientific Advisory Board
      - Dr. Anthony J. Sinskey, Ph.D (Massachusetts Institute of Technology)
    • Completion of SPM™ formula
      - Dr. Chanhwa Kim, Ph.D (Korea University)
  • 2011
    • Establishment of Singapore corporate headquarters, BIOCOZ GLOBAL Pte. Ltd.
    • Establishment of South Korea subsidiary, BIOCOZ GLOBAL Korea Corp.
    • Development of bioactive composition prototype
    • Initiation of cell activating material studies
      - Dr. Chanhwa Kim, Ph.D (Korea University)
  • 2006
    • Initiation of cell growth activating material studies
      - Lead by Dr. Phan Toan Thang, MD, Ph.D (National University Singapore)